'High risk stage' presentation slideshows

ASCO 2010 Biomarker-driven Treatment in Stage II Colon Cancer: When to Hold and When to Fold

ASCO 2010 Biomarker-driven Treatment in Stage II Colon Cancer: When to Hold and When to Fold. Overview of adjuvant clinical trials in stage II colon cancer - results, challenges, and confusion. - Al B. Benson, III, MD

639 views • 45 slides

Diagnosis

404 views • 15 slides

COLON CANCER

COLON CANCER. A MAJOR ISSUE IN ALASKA. A common malignancy. 200,000 cases in the U. S. in 2008 Greater than 50 new cases each year in Alaska Natives . RISK FACTORS. Age Family history Genetic predisposition Adenomatous polyps History of other gastrointestinal malignancies. Screening.

844 views • 13 slides

COLON CANCER

COLON CANCER. A MAJOR ISSUE IN ALASKA. A common malignancy. 200,000 cases in the U. S. in 2008 Greater than 50 new cases each year in Alaska Natives . RISK FACTORS. Age Family history Genetic predisposition Adenomatous polyps History of other gastrointestinal malignancies. Screening.

233 views • 13 slides

Reviewer: Dr Phil Bedard Date posted: June 21, 2007

Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years Authors: Gramont et al. Reviewer: Dr Phil Bedard Date posted: June 21, 2007. Background. MOSAIC trial Primary endpoint = DFS

195 views • 7 slides